| Literature DB >> 25069089 |
Maria Luisa Cotrina1, Michael Chen2, Xiaoning Han2, Jeffrey Iliff2, Zeguang Ren2, Wei Sun2, Tracy Hagemann3, James Goldman4, Albee Messing3, Maiken Nedergaard2.
Abstract
Alexander disease (AxD) is the only known human pathology caused by mutations in an astrocyte-specific gene, glial fibrillary acidic protein (GFAP). These mutations result in abnormal GFAP accumulations that promote seizures, motor delays and, ultimately, death. The exact contribution of increased, abnormal levels of astrocytic mutant GFAP in the development and progression of the epileptic phenotype is not clear, and we addressed this question using two mouse models of AxD. Comparison of brain seizure activity spontaneously and after traumatic brain injury (TBI), an effective way to trigger seizures, revealed that abnormal GFAP accumulation contributes to anomalous brain activity (increased non-convulsive hyperactivity) but is not a risk factor for the development of epilepsy after TBI. These data highlight the need to further explore the complex and heterogeneous response of astrocytes towards injury and the involvement of GFAP in the progression of AxD.Entities:
Keywords: Astrocyte; Epilepsy; GFAP; Glia; Trauma
Mesh:
Substances:
Year: 2014 PMID: 25069089 PMCID: PMC4164594 DOI: 10.1016/j.brainres.2014.07.029
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252